Ticketmaster to refund some fees after The Cure’s Robert Smith says he was ‘sickened’ by prices
One photo posted on Twitter showed that the fees on the Ticketmaster website totaled more than the $20 single ticket price.
First Republic shares slid almost 33% after deposit infusion, dragging down other regional banks
The losses came even after 11 other banks pledged to deposit $30 billion in First Republic for at least 120 days in a coordinated rescue attempt.
YouTube lifts restrictions on Trump’s account
The decision means that Trump’s accounts on three major platforms from which he was restricted are now restored, in time for an expected election campaign.
U.S. judge in Texas will soon rule on the abortion pill mifepristone. Here’s what could happen
The judge could order the FDA to withdraw mifepristone. He could also stop short of blocking sales and impose tougher restrictions on distribution instead.
Venture investors, U.S. lawmakers join forces to fight Tiktok & Chinese influence: WSJ
To fight TikTok and Chinese influence in the U.S., venture investors have teamed up with U.S. lawmakers to form a new working group.
WHO calls on China to release data linking Covid origin to raccoon dogs at Wuhan market
The World Health Organization said new data linking the virus to animal samples at China’s Wuhan Market provides more clues about the Covid pandemic’s origins.
NYSE FANG+ index heads for best week in a year — led by AMD and Meta
Big tech stocks are outperforming this week on the back of a sharp pullback in bond yields.
Google stacks its legal team with former DOJ employees as it faces antitrust cases
Experts say this kind of hiring can be help a company because of the unique insight or credibility an ex-government worker might hold with former colleagues.
Google nixes paying out remainder of maternity and medical leave for laid-off employees
Google’s layoffs announced in January included employees who were on medical and maternity leave and who are now at risk of not getting paid out for time off.
Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
